Regional citrate anticoagulation during continuous renal replacement therapy (CRRT) in a cardiac surgery patient with a high risk of bleeding – case report
Authors:
Zuščich Ondřej; Hájek Roman; Drobiličová Andrea
Authors‘ workplace:
Kardiochirurgická klinika, Fakultní nemocnice Olomouc
Published in:
Anest. intenziv. Med., 20, 2009, č. 5, s. 262-266
Category:
Intesive Care Medicine - Case Report
Overview
Regional citrate anticoagulation is suitable for cardiac surgery patients with clotting abnormalities who require continuous renal replacement therapy (CRRT) in the postoperative period. Case reports point to using regional citrate anticoagulation in patients with a high risk of bleeding and document the possibility of monitoring systemic haemocoagulation during renal replacement therapy using thromboelastography. This method is used as the first option in the case of significant disturbances in blood clotting.
Keywords:
regional anticoagulation – haemocoagulation – bleeding – continuous renal replacement therapy
Sources
1. Kroužecký, A. Antikoagulace u metod mimotělní náhrady funkce ledvin. In: Novák, I., Matějovič, M., Černý, V. et al. Akutní selhání ledvin. Praha : Maxdorf, 2008, p. 85–95.
2. Stašek, J. Trombocytopenie jako komplikace kontinuálních očišťovacích metod. Interní medicína pro praxi, 2005, 7, 10, p. 438–439.
3. Hájek, R., Zezula, R., Fluger, I., Růžičková, J. Význam trombelastografie pro monitorování hemostázy v kardiochirurgii. Intervenční a akutní kardiologie, 2005, 4, 4, p. 224–228.
4. Evenepoel, P., Dejagere, T., Verhamme, P., Claes, K., Kuypers, D., Bammens, B., Vanrenterghem, Y. Heparin-coated polyacrylonitrile membrane versus regional citrate anticoagulation: a prospective randomized study of 2 anticoagulation strategies in patiens at risk of bleeding. Am. J. Kidney Dis., 2007, 49, 5, p. 642–649.
5. Maňák, J., Mottl, R., Sobotka, L. Citrátová antikoagulace během kontinuální veno-venosní hemodiafiltrace – návod na provedení metody. Aktuality v nefrologii, 2006, 6, 4, p. 125–129.
6. Cubattoli, L., Teruzzi, M., Cormio, M., Lampati, L., Pesenti, A. Citrate anticoagulation during CVVH in high risk bleeding patients. Int. J. Artif. Organs, 2007, 30, 3, p. 244–252.
7. Bagshaw, S. M., Laupland, K. B., Boiteau, P. J., Godinez-Luna, T. Is regional citrate superior to systemic heparin antikoagulation for continuous renal replacement therapy? A prospective study in an adult regional critical care system. J. Crit. Care, 2005, 20, 2, p. 155–161.
8. Morgera, S., Scholle, C., Voss, G., Haase, M., Vargas-Hein, O., Krausch, D., Melzer, C., Roseau, S., Zuskermann-Becker, H., Neumayer, H. H. Metabolic complications during regional citrate anticoagulation in continuous venovenous hemodialysis: single-center experience. Nephron. Clin. Pract, 2004, 97, 4, p. 131–136.
9. Betjes, M. G., van Oosterom, D., van Agterem, M., van de Watering, J. Regional citrate versus heparin anticoagulation during venovenous hemofiltration in patients at low risk for bleeding: similar hemofilter survival but significantly less bleeding. J. Nephrol., 2007, 20, 5, p. 602–608.
10. Thoenen, M., Schmid, E. R., Binswanger, U., Schuepbach, R., Aerne, D., Schmidlin, D. Regional citrate anticoagulation using a citrate-based substitution solution for continuous venovenous hemofiltration in cardiac surgery patients. Wien Klin. Wochenschr., 2002, 114, 3, p. 108–114.
Labels
Anaesthesiology, Resuscitation and Inten Intensive Care MedicineArticle was published in
Anaesthesiology and Intensive Care Medicine
2009 Issue 5
Most read in this issue
- Induction and recovery times for general anaesthesia – a prospective study
- Cancellations of scheduled surgical procedures in three Czech university hospitals – a prospective study
- Regional citrate anticoagulation during continuous renal replacement therapy (CRRT) in a cardiac surgery patient with a high risk of bleeding – case report
- Age of packed red blood cells and its influence on concentration of selected biochemical values